Loading
Latest filing published 03 Dec 2025 for NurExone Biologic Inc formerly, EnerSpar Corp, €65k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Lior Shaltiel is a declared insider of NurExone Biologic Inc. (formerly, EnerSpar Corp.), with filings sourced from SEDI. Between 15 June 2022 and 26 November 2025, the trades on record add up to 3 filings.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 3 December 2025, reports a share grant of €65k in NurExone Biologic Inc. (formerly, EnerSpar Corp.). Filings reach the SEDI feed a median of 7 days after the trade. That lag is the time during which only the insider knows about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations